Universitätsklinikum Tübingen

Process Evaluation of a Medical Student-Delivered Smoking Prevention Program for Secondary Schools: Protocol for the Education Against Tobacco Cluster Randomized Trial (2019) Brinker TJ, Buslaff F, Suhre JL, Silchmueller MP, Divizieva E, Wilhelm J, Hillebrand G, et al. Journal article Oncoplastic breast-conserving surgery: More relevant than ever? Results of a survey among breast surgeons (2019) Heil J, Riedel F, Solbach C, Gerber B, Marx M, Brucker S, Heitmann C, et al. Journal article Impact of radiation, systemic therapy and treatment sequencing on survival of patients with melanoma brain metastases (2019) Rauschenberg R, Bruns J, Bruetting J, Daubner D, Lohaus F, Zimmer L, Forschner A, et al. Journal article Combined antifungal therapy is superior to monotherapy in pulmonary scedosporiosis in cystic fibrosis (2019) Schwarz C, Brandt C, Melichar V, Runge C, Heuer E, Sahly H, Schebek M, et al. Journal article Nicht-zöliakie-gluten-/weizen-sensitivität (ncgs) – ein bislang nicht definiertes krankheitsbild mit fehlenden diagnosekriterien und unbekannter häufigkeit (2019) Reese I, Schaefer C, Kleine-Tebbe J, Ahrens B, Bachmann O, Ballmer-Weber B, Beyer K, et al. Journal article The transfection of natural killer T cells with a tumor-antigen specific chimeric antigen receptor (CAR) for melanoma immunotherapy (2019) Simon B, Wiesinger M, Maerz J, Wistuba-Hamprecht K, Weide B, Schuler-Thurner B, Schuler G, et al. Conference contribution Growth in disorders and normal variants of puberty (2019) Binder G, Bettendorf M, Dörr HG, Hauffa BP, Reinehr T, Richter-Unruh A, Rohrer TR, Woelfle J Journal article, Review article Non-celiac gluten/wheat sensitivity (NCGS) - a currently undefined disorder without validated diagnostic criteria and of unknown prevalence (2019) Reese I, Schaefer C, Kleine-Tebbe J, Ahrens B, Bachmann O, Ballmer-Weber B, Beyer K, et al. Journal article Sequence-dependent cross-resistance of combined radiotherapy plus BRAF(V600E) inhibition in melanoma (2019) Shannan B, Matschke J, Chauvistre H, Vogel F, Klein D, Meier F, Westphal D, et al. Journal article Efficacy and safety of everolimus plus exemestane in postmenopausal women with hormone receptor-positive, human epidermal growth factor receptor 2-negative locally advanced or metastatic breast cancer: Results of the single-arm, phase IIIB 4EVER trial (2019) Tesch H, Stoetzer O, Decker T, Kurbacher CM, Marme F, Schneeweiss A, Mundhenke C, et al. Journal article